185 related articles for article (PubMed ID: 3124732)
1. Disk diffusion susceptibility testing of Branhamella catarrhalis with ampicillin and seven other antimicrobial agents.
Doern GV; Tubert T
Antimicrob Agents Chemother; 1987 Oct; 31(10):1519-23. PubMed ID: 3124732
[TBL] [Abstract][Full Text] [Related]
2. Disk diffusion versus broth microdilution susceptibility testing of Haemophilus species and Moraxella catarrhalis using seven oral antimicrobial agents: application of updated susceptibility guidelines of the National Committee for Clinical Laboratory Standards.
Kibsey PC; Rennie RP; Rushton JE
J Clin Microbiol; 1994 Nov; 32(11):2786-90. PubMed ID: 7852573
[TBL] [Abstract][Full Text] [Related]
3. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.
Jorgensen JH; Redding JS; Maher LA; Howell AW
J Clin Microbiol; 1987 Nov; 25(11):2105-13. PubMed ID: 3500965
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
[TBL] [Abstract][Full Text] [Related]
5. Tetracycline and erythromycin resistance among clinical isolates of Branhamella catarrhalis.
Brown BA; Wallace RJ; Flanagan CW; Wilson RW; Luman JI; Redditt SD
Antimicrob Agents Chemother; 1989 Sep; 33(9):1631-3. PubMed ID: 2510597
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
Jorgensen JH; Doern GV; Maher LA; Howell AW; Redding JS
Antimicrob Agents Chemother; 1990 Nov; 34(11):2075-80. PubMed ID: 2127342
[TBL] [Abstract][Full Text] [Related]
7. Ampicillin disk diffusion susceptibility testing of Haemophilus influenzae.
Doern GV; Daum GS; Tubert TA
J Clin Microbiol; 1987 Sep; 25(9):1675-8. PubMed ID: 3498738
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
Powell M; McVey D; Kassim MH; Chen HY; Williams JD
J Antimicrob Chemother; 1991 Aug; 28(2):249-59. PubMed ID: 1778856
[TBL] [Abstract][Full Text] [Related]
9. β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China.
Shi W; Wen D; Chen C; Yuan L; Gao W; Tang P; Cheng X; Yao K
BMC Microbiol; 2018 Jul; 18(1):77. PubMed ID: 30029595
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of Moraxella catarrhalis to 21 antimicrobial drugs: validity of current NCCLS criteria for the interpretation of agar disk diffusion antibiograms.
Traub WH; Leonhard B
Chemotherapy; 1997; 43(3):159-67. PubMed ID: 9142455
[TBL] [Abstract][Full Text] [Related]
11. Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production.
Luman I; Wilson RW; Wallace RJ; Nash DR
Antimicrob Agents Chemother; 1986 Nov; 30(5):774-6. PubMed ID: 3492178
[TBL] [Abstract][Full Text] [Related]
12. Development of a disk diffusion method for testing Moraxella catarrhalis susceptibility using clinical and laboratory standards institute methods: a SENTRY antimicrobial surveillance program report.
Bell JM; Turnidge JD; Jones RN
J Clin Microbiol; 2009 Jul; 47(7):2187-93. PubMed ID: 19458179
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.
Doern GV; Brueggemann AB; Pierce G; Hogan T; Holley HP; Rauch A
Antimicrob Agents Chemother; 1996 Dec; 40(12):2884-6. PubMed ID: 9124860
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of Branhamella catarrhalis to antibiotics].
Leszczyńska K; Jakoniuk P; Sacha PT; Zalewska M; Wieczorek P
Med Dosw Mikrobiol; 2004; 56(3):231-7. PubMed ID: 15773499
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
Shelton MM; Welch DF
Chemotherapy; 1989; 35(2):88-94. PubMed ID: 2788068
[TBL] [Abstract][Full Text] [Related]
16. The antimicrobial susceptibility of Moraxella catarrhalis isolated in England and Scotland in 1991.
Fung CP; Powell M; Seymour A; Yuan M; Williams JD
J Antimicrob Chemother; 1992 Jul; 30(1):47-55. PubMed ID: 1429336
[TBL] [Abstract][Full Text] [Related]
17. Problems with current recommendations for susceptibility testing of Haemophilus influenzae.
Mendelman PM; Wiley EA; Stull TL; Clausen C; Chaffin DO; Onay O
Antimicrob Agents Chemother; 1990 Aug; 34(8):1480-4. PubMed ID: 2221855
[TBL] [Abstract][Full Text] [Related]
18. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
Yeo SF; Livermore DM
J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
[TBL] [Abstract][Full Text] [Related]
19. Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates.
Jorgensen JH; Crawford SA; Fulcher LC; Glennen A; Harrington SM; Swenson J; Lynfield R; Murray PR; Tenover FC
J Clin Microbiol; 2006 May; 44(5):1744-54. PubMed ID: 16672402
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
